Smooth Drug Development May 2020 News Release

We were working on the following new projects in May:

• Smooth Drug Development signed several contracts for medical writing

• We signed a contract for organization of phase III clinical trial with INN: Buserelinum

• We are negotiating an agreement for pharmacovigilance activities.

Clinical Department News

• Clinical study report was prepared for erlotinib project.

• Site Selection visits are being performed by our team in COVID-19 trial.

• Close out visits were performed in Lopinavir and Ritonavir project

• Enrollment in flu vaccine study is completed ahead of schedule

Our BD plans to participate in Bio Virtual Partnering conference